Total Payments
$5,710
2024 Payments
$840.62
Companies
33
Transactions
324
Medicare Patients
3,429
Medicare Billing
$356,461
Payment Breakdown by Category
Food & Beverage$5,695 (99.7%)
Consulting$14.99 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,695 | 323 | 99.7% |
| Consulting Fee | $14.99 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,063 | 131 | $0 (2024) |
| Gilead Sciences, Inc. | $619.32 | 18 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $489.89 | 25 | $0 (2024) |
| Allergan Inc. | $480.36 | 32 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $207.87 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $205.75 | 15 | $0 (2024) |
| Celgene Corporation | $176.03 | 10 | $0 (2023) |
| PFIZER INC. | $161.29 | 10 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $151.25 | 3 | $0 (2021) |
| Covidien LP | $150.05 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $840.62 | 56 | ABBVIE INC. ($549.94) |
| 2023 | $433.11 | 26 | AbbVie Inc. ($266.09) |
| 2022 | $836.48 | 40 | ABBVIE INC. ($437.07) |
| 2021 | $564.86 | 31 | AbbVie Inc. ($261.82) |
| 2020 | $346.93 | 22 | AbbVie Inc. ($143.88) |
| 2019 | $774.91 | 44 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($228.46) |
| 2018 | $852.33 | 53 | AbbVie, Inc. ($234.28) |
| 2017 | $1,060 | 52 | Allergan Inc. ($282.65) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: VIROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: VIROLOGY | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.25 | General |
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: VIROLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: VIROLOGY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.26 | General |
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Immunology | ||||||
| 08/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.26 | General |
| 07/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 673 | 793 | $339,356 | $67,320 |
| 2022 | 13 | 738 | 849 | $392,618 | $77,425 |
| 2021 | 16 | 1,015 | 1,204 | $506,962 | $107,132 |
| 2020 | 20 | 1,003 | 1,317 | $487,361 | $104,583 |
Total Patients
3,429
Total Services
4,163
Medicare Billing
$356,461
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 111 | 112 | $105,616 | $22,329 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 217 | $59,892 | $13,067 | 21.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 99 | $20,790 | $5,963 | 28.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 72 | 73 | $43,800 | $5,478 | 12.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 46 | $18,400 | $4,503 | 24.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 102 | 108 | $18,360 | $3,938 | 21.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 21 | 21 | $15,687 | $3,553 | 22.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $11,526 | $2,665 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 25 | $9,800 | $1,937 | 19.8% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 12 | 12 | $15,588 | $1,530 | 9.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $15,067 | $1,220 | 8.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 15 | $3,450 | $682.65 | 19.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 12 | $1,380 | $455.16 | 33.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 133 | 134 | $126,362 | $25,889 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 190 | 253 | $69,828 | $15,437 | 22.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 78 | 78 | $46,800 | $6,627 | 14.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 49 | $19,600 | $5,063 | 25.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 90 | $18,900 | $4,894 | 25.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 29 | 29 | $21,663 | $4,876 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 48 | $18,700 | $3,480 | 18.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 63 | 64 | $10,880 | $2,412 | 22.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 37 | 37 | $29,341 | $2,282 | 7.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $11,205 | $2,125 | 19.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $7,644 | $1,976 | 25.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $8,475 | $1,733 | 20.4% |
About Dr. Edward Rydzak, MD
Dr. Edward Rydzak, MD is a Gastroenterology healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639157266.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Rydzak, MD has received a total of $5,710 in payments from pharmaceutical and medical device companies, with $840.62 received in 2024. These payments were reported across 324 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,695).
As a Medicare-enrolled provider, Rydzak has provided services to 3,429 Medicare beneficiaries, totaling 4,163 services with total Medicare billing of $356,461. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Savannah, GA
- Active Since 01/04/2006
- Last Updated 02/13/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639157266
Products in Payments
- RINVOQ (Biological) $766.49
- XIFAXAN (Drug) $436.30
- LINZESS (Drug) $384.54
- HUMIRA (Biological) $343.65
- MAVYRET (Drug) $309.10
- Vemlidy (Drug) $240.18
- VIBERZI (Drug) $234.13
- STELARA (Biological) $215.07
- Humira (Biological) $180.63
- ZEPOSIA (Drug) $160.40
- Barrx (Device) $150.05
- XELJANZ (Drug) $149.81
- SPYGLASS (Device) $109.27
- DIFICID (Drug) $108.35
- CREON (Drug) $106.33
- Mavyret (Drug) $101.57
- Creon (Drug) $93.81
- Entyvio (Biological) $86.48
- ENTYVIO (Biological) $84.94
- Cimzia (Drug) $80.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Savannah
Dr. Daniel Mullady, Md, MD
Gastroenterology — Payments: $119,628
Gastroenterology $119,628
George Aragon, Md, MD
Gastroenterology — Payments: $17,588
Gastroenterology $17,588
Travis Wiggins, M.d, M.D
Gastroenterology — Payments: $17,255
Gastroenterology $17,255
Dr. John Northup, M.d, M.D
Gastroenterology — Payments: $14,252
Gastroenterology $14,252
Ryan Wanamaker, Md, MD
Gastroenterology — Payments: $13,508
Gastroenterology $13,508
Mark Nyce, Md, MD
Gastroenterology — Payments: $10,771
Gastroenterology $10,771